Evermore Global Advisors’s Enzo Biochem, Inc. ENZ Stock Holding History
Bought
Maintained
Sold
Other funds holding ENZ
HFA
RAM
VCA
AE
Evermore Global Advisors's ENZ Position: Q4 2021 in Review
Evermore Global Advisors sold out of Enzo Biochem, Inc. (ENZ) in Q4 2021, closing a stake of 1,730,607 shares — an estimated $6.13M sold.
Evermore Global Advisors first reported a position in ENZ in Q4 2016 and held it in 18 quarters. The position peaked at $39.3M in Q2 2017. 59 funds tracked by Wall St. Rank hold ENZ as of Q4 2021.
- Evermore Global Advisors reported no remaining Enzo Biochem, Inc. position as of Q4 2021 after selling out during the quarter.
- Evermore Global Advisors sold 1,730,607 Enzo Biochem, Inc. shares in Q4 2021, an estimated $6.13M.
- Evermore Global Advisors first reported a position in Enzo Biochem, Inc. in Q4 2016 and held it in 18 quarters.
- Evermore Global Advisors's Enzo Biochem, Inc. position peaked at $39.3M in Q2 2017.
- 59 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q4 2021.
Based on Evermore Global Advisors's 13F filing for Q4 2021, filed 20 Jan 2022.